Global Biochip Market 2017-2021

  • ID: 4380346
  • Report
  • Region: Global
  • 79 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • MORE
About Biochip

Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.

The analysts forecast the global biochip market to grow at a CAGR of 17.53% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biochip market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • APAC
  • Europe
  • North America
  • ROW
The report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Agilent Technologies
  • Illumina
  • PerkinElmer
  • Thermo Fisher Scientific
Other prominent vendors
  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • Fluidigm
  • SuperBioChips Laboratories
  • US Biomax
Market drivers
  • Increase in market presence with collaboration strategy
  • For a full, detailed list, view the full report
Market challenges
  • Standardization and accuracy issues
  • For a full, detailed list, view the full report
Market trends
  • Growth in bioinformatics software industry
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
  • Market size and forecast
  • Five forces analysis
PART 05: Market segmentation by fabrication technology
  • Global biochip market by microarrays
  • Global biochip market by microfluidics
PART 06: Geographical segmentation
  • Biochip market in Americas
  • Biochip market in EMEA
  • Biochip market in APAC
PART 07: Decision framework

PART 08: Drivers and challenges
  • Market drivers
  • Market challenges
PART 09: Market trends
  • Increasing POC diagnostics
  • Growing application of biochips in pharmacogenomics
  • Rise in vendors' strategic initiatives
  • Increasing use of biochip technology as alternative to animal testing
PART 10: Vendor landscape
  • Competitive scenario
  • Investment opportunity
PART 11: Key vendor analysis
  • Agilent Technologies
  • GE Healthcare
  • PerkinElmer
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 12: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Types of biochips and their applications
Exhibit 02: The biochip platform
Exhibit 03: Global biochip market: Overview
Exhibit 04: Global biochip market 2016-2021 ($ billions)
Exhibit 05: Significance of biochip in different sectors
Exhibit 06: Factors impacting global biochip market
Exhibit 07: Five forces analysis
Exhibit 08: Global biochip market by fabrication technology 2016-2021 (% share)
Exhibit 09: Global biochip market by fabrication technology: Snapshot
Exhibit 10: Global biochip market by microarrays 2016-2021 ($ billions)
Exhibit 11: Applications of DNA microarrays
Exhibit 12: Global biochip market by microfluidics 2016-2021 ($ billions)
Exhibit 13: Applications of lab-on-a-chip
Exhibit 14: Global biochip market by geography 2016-2021 (% share)
Exhibit 15: Global biochip market by geography: Snapshot
Exhibit 16: Growth perspective in developed and developing market
Exhibit 17: Biochip market in Americas 2016-2021 ($ billions)
Exhibit 18: Programs held by companies in global biochip market
Exhibit 19: Biochip market in EMEA 2016-2021 ($ billions)
Exhibit 20: Biochip market in APAC 2016-2021 ($ billions)
Exhibit 21: Biochips in testing agriculture products
Exhibit 22: Major chronic disease-related deaths 2012 (in thousands)
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Agilent Technologies: Profile
Exhibit 26: Agilent Technologies: Strength analysis
Exhibit 27: Agilent Technologies: Strategy assessment
Exhibit 28: Agilent Technologies: Opportunity assessment
Exhibit 29: GE Healthcare: Profile
Exhibit 30: GE Healthcare: Strength analysis
Exhibit 31: GE Healthcare: Strategy assessment
Exhibit 32: GE Healthcare: Opportunity assessment
Exhibit 33: PerkinElmer: Profile
Exhibit 34: PerkinElmer: Strength analysis
Exhibit 35: PerkinElmer: Strategy assessment
Exhibit 36: PerkinElmer: Opportunity assessment
Exhibit 37: Thermo Fisher Scientific: Profile
Exhibit 38: Thermo Fisher Scientific: Strength analysis
Exhibit 39: Thermo Fisher Scientific: Strategy assessment
Exhibit 40: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • MORE
New Report Released: - Global Biochip Market 2017-2021

The author of the report recognizes the following companies as the key players in the global biochip market: Abbott, Agilent Technologies, Illumina, PerkinElmer, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: BioChain, Bio-Rad Laboratories, Cepheid, EMD Millipore, Fluidigm, SuperBioChips Laboratories, and US Biomax.

Commenting on the report, an analyst from the research team said: “One trend in the market is growth in bioinformatics software industry. Bioinformatics software is a tool that is used in data collection, mining, database construction, and analysis of data. This tool is used in to create analysis results out of the massive amount of data that had been already collected. Along with this, bioinformatics software is also used in the field of genomics and proteomics. It helps in the identification and analysis of abnormalities in the genome of an organism.”

According to the report, one driver in the market is increase in market presence with collaboration strategy. The competition in this market is intense as the number of players is high. The players are competing among themselves based on technology and price. Apart from these two factors, another factor that differentiates these competitors from each other is their presence in the market. Players increase their market presence by collaborating with those companies that own bio-content. Research says that companies generate around 60% better results when they work in collaborations. This increases their profit margins. They collaborate with each other for R&D, financial resources, and intellectual properties.

Further, the report states that one challenge in the market is standardization and accuracy issues. With opportunities, come challenges and limitations. The same is the case with biotechnology. At one side, it has ample uses in medical and drug discovery, but there are challenges too that are limiting the use of biotechnology. One of the limitations of microarrays is the lack of accuracy. To avoid any problems later, all the people associated with it prefers to adhere to standardization and guidelines to study and analyze DNA. Another challenge is standardization of the information received from various platforms. If this practice is not followed, it may result in a serious loss of data available on the chip.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • Agilent Technologies
  • Illumina
  • PerkinElmer
  • Thermo Fisher Scientific
  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • Fluidigm
  • SuperBioChips Laboratories
  • US Biomax
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll